Morris Haynes says they have been contacted by patients in Cullman, Madison, Shelby, and Tallapoosa counties
Key Players Major pharmaceutical companies dominating the GLP-1 analogues market include: Novo Nordisk A/S Market leader with semaglutide and liraglutide brands Eli Lilly and Company Developer of dulaglutide (Trulicity) and advancing new compounds like tirzepatide (dual GIP/GLP-1) AstraZeneca Previously marketed Bydureon and Byetta (exenatide) Pfizer and Amgen Emerging players with GLP-1 drugs in development Future Outlook The future of the GLP-1 analogues market lies not only in expanding use for type 2 diabetes and obesity but also in potential novel indications like non-alcoholic steatohepatitis (NASH), polycystic ovary syndrome (PCOS), and Alzheimers disease
So, why doesnt Henry Meds semaglutide score a 10 out of 10
PCOS, perimenopause, and high cortisol from chronic stress or steroid use all affect weight loss response to GLP-1s
It is known that some polymorphism of MTHFR would result in reduction of MTHFR enzyme activity as well as DNA methylation process, later shown to have significant impacts in various psychiatric diseases
SchreckenbergerMFEgleUTDreckerSBuchholzHGWeberMMBartensteinPet al